
 [
{
"symbol" : "501179",
"exchange" : "BOM",
"id": "715531",
"t" : "501179",
"e" : "BOM",
"name" : "Oscar Investments Ltd."
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=OSCA.BO",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:501179"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:501179"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:501179"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q1 (Mar \u002708)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "17.57%",
"annual" : "30.73%",
"ttm" : "29.05%"
},
{
"title" : "Operating margin",
"recent_quarter" : "21.87%",
"annual" : "30.69%",
"ttm" : "32.30%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "71.37%",
"ttm" : "80.47%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "3.35%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "4.98%",
"ttm" : ""
}
]
, "c" : "-28.85",
"l" : "124.65",
"cp" : "-18.79",
"ccol" : "chr",
"op" : "155.00",
"hi" : "155.00",
"lo" : "123.15",
"vo" : "26,169.00",
"avvo" : "",
"hi52" : "408.90",
"lo52" : "123.15",
"mc" : "2.13B",
"pe" : "10.45",
"fwpe" : "",
"beta" : "",
"eps" : "11.92",
"dy" : "",
"ldiv" : "",
"shares" : "17.28M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "715531",
"name" : "Oscar Investments Ltd.",
"t" : "501179",
"e" : "BOM",
"l" : "124.65",
"c" : "-28.85",
"mc" : "2.13B",
"cp" : "-18.79",
"ccol" : "chr"
}
,
{
"id" : "8292212",
"name" : "Lead Financial Services Ltd",
"t" : "531288",
"e" : "BOM",
"l" : "8.34",
"c" : "+0.39",
"mc" : "27.52M",
"cp" : "4.91",
"ccol" : "chg"
}
,
{
"id" : "179887",
"name" : "Vaarad Ventures Ltd",
"t" : "532320",
"e" : "BOM",
"l" : "17.10",
"c" : "0.00",
"mc" : "4.27B",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "8020305",
"name" : "Monnet Project Developers Ltd",
"t" : "532723",
"e" : "BOM",
"l" : "13.00",
"c" : "+0.55",
"mc" : "96.36M",
"cp" : "4.42",
"ccol" : "chg"
}
,
{
"id" : "8218808",
"name" : "Prism Medico and Pharmacy Ltd",
"t" : "512217",
"e" : "BOM",
"l" : "30.50",
"c" : "+1.00",
"mc" : "184.93M",
"cp" : "3.39",
"ccol" : "chg"
}
,
{
"id" : "10626124",
"name" : "Beeyu Overseas Ltd",
"t" : "532645",
"e" : "BOM",
"l" : "0.35",
"c" : "-0.01",
"mc" : "4.95M",
"cp" : "-2.78",
"ccol" : "chr"
}
,
{
"id" : "4162305",
"name" : "PALCO Ltd",
"t" : "513405",
"e" : "BOM",
"l" : "0.20",
"c" : "0.00",
"mc" : "11.75M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "4203240",
"name" : "Namtech Electronics Devices Ltd",
"t" : "517269",
"e" : "BOM",
"l" : "0.00",
"c" : "",
"mc" : "",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "11055189",
"name" : "JSW Holdings Ltd",
"t" : "JSWHL",
"e" : "NSE",
"l" : "1,760.00",
"c" : "+9.90",
"mc" : "19.43B",
"cp" : "0.57",
"ccol" : "chg"
}
,
{
"id" : "14947817",
"name" : "Aeonian Investments Co Ltd",
"t" : "503655",
"e" : "BOM",
"l" : "185.00",
"c" : "0.00",
"mc" : "946.96M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "10690395",
"name" : "Ganon Trading Finance Co Ltd",
"t" : "512443",
"e" : "BOM",
"l" : "3.15",
"c" : "0.00",
"mc" : "28.72M",
"cp" : "0.00",
"ccol" : "chb"
}
]
, "summary" : [{
"address": "54, Janpath, NEW DELHI, 110001, India",
"phone": "+91-11-40188100",
"fax": "+91-11-40188151",
"url": "http:\u002F\u002Fwww.oscarinvestments.org\u002F",
"overview" : "Oscar Investments Limited is a non-banking finance company. The Company is engaged in the business of income from financial activity. The Company focuses on the business of an investment company, finances industrial enterprise, and promotes companies engaged in industrial and trading business. The Company has a subsidiary Shimal Research Laboratories Limited and a sub-subsidiary, Fortis Clinical Research Limited. Fortis Clinical Research Limited is engaged in the business of conducting bio-equivalence research in India."
} ]
,"moreresources" : [
]
}]
